STOCK TITAN
  1. Home
  2. Sec-filings
  3. VOR
  4. [EFFECT] Vor Biopharma Inc. SEC Filing

[EFFECT] Vor Biopharma Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 4, 2026 4:00 P.M.
Form: S-3
CIK: 0001817229
Company Name: Vor Biopharma Inc.
File Number: 333-293052

Source: View Original Filing on SEC EDGAR

Vor Biopharma Inc.

NASDAQ:VOR

View VOR Stock Overview →

VOR Rankings

#3244 Ranked by Market Cap
N/A Ranked by Dividends
#75 Top Gainer

VOR Latest News

Mar 30, 2026
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 30, 2026
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
Mar 27, 2026
Vor Bio Announces $75 Million Private Placement with TCGX
Mar 23, 2026
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 23, 2026
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference

VOR Latest SEC Filings

Mar 30, 2026
[10-K] Vor Biopharma Inc. Files Annual Report
Mar 27, 2026
[8-K] Vor Biopharma Inc. Reports Material Event
Mar 16, 2026
[SCHEDULE 13D/A] Vor Biopharma Inc. Amended Major Shareholder Report
Feb 17, 2026
[SCHEDULE 13G/A] Vor Biopharma Inc. Amended Passive Investment Disclosure
Feb 17, 2026
[SCHEDULE 13G/A] Vor Biopharma Inc. Amended Passive Investment Disclosure

VOR Stock Data

610.34M
36.70M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
BOSTON